As confirmation of this carcinogenic genetic landscape, Demopoulos et al. found a large mutational burden in several tumor-suppressing genes, comprehending FHIT and TP53, in IPF blood and sputum samples [84]. This evidence concerns the gene TP53 and idiopathic pulmonary fibrosis.